Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
Cancer Res
; 83(19): 3252-3263, 2023 10 02.
Article
in En
| MEDLINE
| ID: mdl-37339176
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Head and Neck Neoplasms
Limits:
Humans
Language:
En
Journal:
Cancer Res
Year:
2023
Document type:
Article